This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.

TargetInvestorsAmountDate
Theranics Bio-ElectronicsLightspeed Venture Partners, LionBird and Corundum Open Innovation$6 million, Series AJuly 3, 2017
Diasome Pharmaceuticals, Inc.Medicxi Ventures, JDRF T1D Fund, Black Beret Life Sciences, LLC and McDonald Partners, LLC$30 millionJuly 5, 2017
Omni Eye ServicesNew MainStream CapitalUndisclosedJuly 6, 2017
GenooxInimiti Capital Partners and Glilot Capital$6 millionJuly 11, 2017
Allurion TechnologiesRomulus Capital, with Cogepa Investments and IDO Investments$27 million, Series CJuly 11, 2017
Evelo BiosciencesFlagship Pioneering, Google Ventures, Celgene, Mayo Clinic and Alexandria Venture Investments$50 million, Series BJuly 11, 2017
Machtfit Seventure Partners$2.6 million, Series AJuly 11, 2017
Push DoctorSeventure Partners$27.1 million, Series BJuly 11, 2017
Actinobac BiomedKairos Ventures$4.4 millionJuly 12, 2017
BloomAPIY Combinator, Slow Ventures, Founders' Co-Op, Section 32, Liquid 2 Ventures and Parker Conrad$2.4 millionJuly 14, 2017
Bright.mdB Capital Group and Seven Peaks Ventures$8 million, Series BJuly 17, 2017
Silk Road MedicalNorthwest Venture Partners, with Janus Capital Management, Warburg Pincus, the Vertical Group and CRG$47 millionJuly 18, 2017
Trevi TherapeuticsNew Enterprise Associates, with TPG Biotech, Lundebeckfonden Ventures, Omega Funds and Aperture Venture Partners$50.5 million, Series CJuly 20, 2017
Allegro OphthalmicsNot disclosed$10.7 million July 24, 2017
Sebacia, Inc. Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund$20 million, Series DJuly 25, 2017
Okami MedicalInceptus Medical, LLC$4.5 million, Series BJuly 25, 2017
VenatoRx Pharmaceuticals, Inc. Versant Ventures, with Abingworth and Foresite Capital$42 million, Series CJuly 25, 2017
PreciTheraSanderling Ventures, Arix Bioscience, Fons de solidarite FTQ, CTI Life Scienes and Emerillon Capital$29 million, Series AJuly 27, 2017